Antimicrobial resistance (AMR) is a major global health threat that has already reached alarming levels. Aidian takes part in supporting ant...
Aidian is pleased to announce that Matthias Borst and Dr. Michael Hausmann have been appointed to the company’s board of directors. Both hav...
A new poster about QuikRead go® HbA1c is out now! A new poster about QuikRead go® HbA1c is out now! A study conducted in the Netherlands sh...
Antimicrobial resistance (AMR) is an emerging health threat, but the COVID-19 pandemic set back many actions already combating AMR. Before C...
Aidian has published A Guide to Monitoring Surface Hygiene which reviews several methodological options for hygiene monitoring. The guide al...
Antimicrobial resistance (AMR) is a growing global health threat that has already reached alarming levels. According to a recent study even ...
Antimicrobial resistance (AMR) is a major global health threat. Aidian takes part in supporting antimicrobial stewardship and sustainable us...
The new In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR) entered into application on 26 May 2022. The new regulation will...